Avoro Capital Advisors LLC Iovance Biotherapeutics, Inc. Transaction History

Avoro Capital Advisors LLC

  • $8.3 Billion
  • Q1 2024

A detailed history of Avoro Capital Advisors LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 11,700,000 shares of IOVA stock, worth $93.8 Million. This represents 2.09% of its overall portfolio holdings.

Number of Shares
11,700,000
Previous 6,700,000 74.63%
Holding current value
$93.8 Million
Previous $54.5 Million 218.32%
% of portfolio
2.09%
Previous 0.78%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$7.59 - $17.47 $38 Million - $87.4 Million
5,000,000 Added 74.63%
11,700,000 $173 Million
Q2 2023

Aug 14, 2023
SELL
$5.36 - $9.06 $1.72 Million - $2.9 Million
-320,000 Reduced 4.56%
6,700,000 $47.2 Million
Q4 2022

Feb 14, 2023
SELL
$5.62 - $10.0 $11.2 Million - $20 Million
-2,000,000 Reduced 22.17%
7,020,000 $44.9 Million
Q3 2022

Nov 14, 2022
SELL
$9.53 - $13.11 $1.91 Million - $2.62 Million
-200,000 Reduced 2.17%
9,020,000 $86.4 Million
Q2 2022

Aug 15, 2022
BUY
$6.38 - $18.33 $606,100 - $1.74 Million
95,000 Added 1.04%
9,220,000 $102 Million
Q1 2022

May 16, 2022
BUY
$12.38 - $19.1 $5.57 Million - $8.6 Million
450,000 Added 5.19%
9,125,000 $152 Million
Q4 2021

Feb 14, 2022
BUY
$16.55 - $27.63 $2.9 Million - $4.84 Million
175,000 Added 2.06%
8,675,000 $166 Million
Q3 2021

Nov 15, 2021
SELL
$20.35 - $26.63 $12.2 Million - $16 Million
-600,000 Reduced 6.59%
8,500,000 $210 Million
Q2 2021

Aug 16, 2021
BUY
$16.33 - $33.07 $18 Million - $36.4 Million
1,100,000 Added 13.75%
9,100,000 $237 Million
Q1 2021

May 17, 2021
BUY
$28.67 - $52.59 $14.3 Million - $26.3 Million
500,000 Added 6.67%
8,000,000 $253 Million
Q4 2020

Feb 16, 2021
SELL
$28.04 - $50.26 $57.1 Million - $102 Million
-2,036,039 Reduced 21.35%
7,500,000 $348 Million
Q3 2020

Nov 16, 2020
SELL
$27.75 - $36.3 $22.9 Million - $29.9 Million
-825,000 Reduced 7.96%
9,536,039 $314 Million
Q2 2020

Aug 14, 2020
BUY
$27.21 - $41.0 $36.8 Million - $55.4 Million
1,350,626 Added 14.99%
10,361,039 $284 Million
Q1 2020

May 15, 2020
BUY
$19.54 - $38.85 $3.6 Million - $7.16 Million
184,374 Added 2.09%
9,010,413 $270 Million
Q4 2019

Feb 14, 2020
SELL
$17.95 - $29.41 $31.9 Million - $52.2 Million
-1,775,000 Reduced 16.74%
8,826,039 $244 Million
Q3 2019

Nov 14, 2019
SELL
$17.99 - $26.0 $2.73 Million - $3.94 Million
-151,546 Reduced 1.41%
10,601,039 $193 Million
Q2 2019

Aug 14, 2019
BUY
$9.78 - $24.52 $2.17 Million - $5.44 Million
221,723 Added 2.11%
10,752,585 $264 Million
Q1 2019

May 15, 2019
BUY
$8.41 - $11.26 $2.27 Million - $3.04 Million
269,823 Added 2.63%
10,530,862 $100 Million
Q4 2018

Feb 14, 2019
BUY
$7.51 - $11.93 $12 Million - $19.1 Million
1,598,319 Added 18.45%
10,261,039 $90.8 Million
Q3 2018

Nov 14, 2018
BUY
$11.25 - $17.7 $5.46 Million - $8.58 Million
485,000 Added 5.93%
8,662,720 $97.5 Million
Q2 2018

Aug 14, 2018
BUY
$12.45 - $16.95 $1.24 Million - $1.68 Million
99,215 Added 1.23%
8,177,720 $105 Million
Q1 2018

May 15, 2018
BUY
$8.1 - $19.5 $22.9 Million - $55.1 Million
2,825,055 Added 53.78%
8,078,505 $137 Million
Q4 2017

Feb 14, 2018
BUY
$6.65 - $9.25 $7 Million - $9.73 Million
1,052,107 Added 25.04%
5,253,450 $42 Million
Q3 2017

Nov 14, 2017
BUY
$4.45 - $8.55 $18.7 Million - $35.9 Million
4,201,343
4,201,343 $32.6 Million

Others Institutions Holding IOVA

# of Institutions
303
Shares Held
221M
Call Options Held
3.05M
Put Options Held
1.6M
View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

IOVA Quotes by TradingView
  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.27B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Avoro Capital Advisors LLC Portfolio

Follow Avoro Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email